These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 18762079

  • 1. Juxtafoveal telangiectasias.
    Querques G, Delle Noci N.
    Ophthalmology; 2008 Sep; 115(9):1636; author reply 1636. PubMed ID: 18762079
    [No Abstract] [Full Text] [Related]

  • 2. Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia.
    Charbel Issa P, Holz FG, Scholl HP.
    Ophthalmology; 2007 Sep; 114(9):1736-42. PubMed ID: 17822979
    [Abstract] [Full Text] [Related]

  • 3. Intravitreous ranibizumab as treatment for macular telangiectasia type 2.
    Lira RP, Silva VB, Cavalcanti TM, de Souza AC, Pinto AP.
    Arch Ophthalmol; 2010 Aug; 128(8):1075-8. PubMed ID: 20697014
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combined intravitreal bevacizumab and argon laser treatment for Coats' disease.
    Cackett P, Wong D, Cheung CM.
    Acta Ophthalmol; 2010 Mar; 88(2):e48-9. PubMed ID: 19500078
    [No Abstract] [Full Text] [Related]

  • 7. Intravitreal pegaptanib reduces fluorescein leakage in idiopathic parafoveal telangiectasis.
    Vianna RN, Squeri G, Turquetti R, Brasil OF, Burnier MN.
    Can J Ophthalmol; 2008 Aug; 43(4):492-3. PubMed ID: 18711476
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of idiopathic juxtafoveolar retinal telangiectasis with bevacizumab (avastin)].
    Schulze S, Mennel S.
    Klin Monbl Augenheilkd; 2007 Oct; 224(10):787-90. PubMed ID: 17952823
    [Abstract] [Full Text] [Related]

  • 9. Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia.
    Rishi P, Rishi E, Shroff D.
    Indian J Ophthalmol; 2009 Oct; 57(3):241-2. PubMed ID: 19384026
    [No Abstract] [Full Text] [Related]

  • 10. Intravitreal bevacizumab therapy for idiopathic macular telangiectasia.
    Matsumoto Y, Yuzawa M.
    Jpn J Ophthalmol; 2010 Jul; 54(4):320-4. PubMed ID: 20700800
    [Abstract] [Full Text] [Related]

  • 11. Intravitreal bevacizumab compared with photodynamic therapy with verteporfin for group 2a parafoveal retinal telangiectasis.
    Windisch R, Kozousek V.
    Can J Ophthalmol; 2008 Aug; 43(4):489-90. PubMed ID: 18711474
    [No Abstract] [Full Text] [Related]

  • 12. Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II.
    Kovach JL, Rosenfeld PJ.
    Retina; 2009 Jan; 29(1):27-32. PubMed ID: 18936721
    [Abstract] [Full Text] [Related]

  • 13. Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation.
    Meyerle CB, Freund KB, Iturralde D, Spaide RF, Sorenson JA, Slakter JS, Klancnik JM, Fisher YL, Cooney MJ, Yannuzzi LA.
    Retina; 2007 Jan; 27(4):451-7. PubMed ID: 17420697
    [Abstract] [Full Text] [Related]

  • 14. Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis.
    Alldredge CD, Garretson BR.
    Retina; 2003 Feb; 23(1):113-6. PubMed ID: 12652245
    [No Abstract] [Full Text] [Related]

  • 15. Intravitreal bevacizumab (Avastin) in idiopathic retinitis, vasculitis, aneurysms and neuroretinitis.
    Akesbi J, Brousseaud FX, Adam R, Rodallec T, Nordmann JP.
    Acta Ophthalmol; 2010 Mar; 88(2):e40-1. PubMed ID: 19508455
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intravitreal bevacizumab injection for central serous chorioretinopathy.
    Nowroozzadeh MH.
    Retina; 2010 Sep; 30(8):1322-3; author reply 1323. PubMed ID: 20827148
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Re: Optical coherence tomography findings in nonproliferative group 2a idiopathic juxtafoveal retinal telangiectasis.
    Querques G, Delle Noci N.
    Retina; 2008 Feb; 28(2):368-9; author reply 369-70. PubMed ID: 18301049
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.